Board Member
Travere Therapeutics, Inc. (TVTX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Recorded current and former roles; source labels appear when available.
2019-01-01–present
Recorded roles and earnings-call appearances connecting this person to public companies.
CEO, Board Member
2019-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Travere Therapeutics, Inc. (TVTX) | President, Chief Executive Officer and Director | $854,250 | $8,457,151 |
| 2024 | Travere Therapeutics, Inc. (TVTX) | President, Chief Executive Officer and Director | $822,000 | $5,204,877 |
| 2023 | Travere Therapeutics, Inc. (TVTX) | President, Chief Executive Officer and Director | $795,834 | $7,574,959 |
| 2022 | Travere Therapeutics, Inc. (TVTX) | President, Chief Executive Officer and Director | $746,667 | $5,753,490 |
| 2021 | Travere Therapeutics, Inc. (TVTX) | President, Chief Executive Officer and Director | $708,021 | $5,739,010 |
| 2020 | Travere Therapeutics, Inc. (TVTX) | President, Chief Executive Officer and Director | $660,938 | $5,447,879 |
| 2019 | Travere Therapeutics, Inc. (TVTX) | President, Chief Executive Officer and Director | $618,188 | $9,679,319 |
Earnings-call appearances and filed executive appointments or departures, newest first.
